ReturnTo Theme-Group-Choice | Onelevelup |
4B024 | MUTATION OR GENETIC ENGINEERING | |
C12N15/00 -15/90,104@Z |
C12N15/00@A;15/00@B;15/00@C;15/00@D;15/00@F;15/00@G;15/00@H;15/00@J;15/00@K;15/00@L | AA | AA00 FIELD OF APPLICATION |
AA01 | AA03 | AA05 | AA07 | AA08 | AA10 | ||||
. Medicines for treatment or prevention | . Chemical industries | . Foods or brewing | . Agriculture | . . Plant breeding | . Animal husbandries and fisheries | |||||||
AA11 | AA12 | AA13 | AA14 | AA15 | AA17 | AA19 | AA20 | |||||
. Analysis or diagnosis | . . Cancers or tumours | . . Infectious diseases | . . . Viral infections | . . Cell surface antigens | . Resources energy or environmental protection | . Apparatus electronics | . Genetic engineering basic technologies or others | |||||
BA | BA00 PRODUCTION SUBSTANCE TO BE TARGETED |
BA01 | BA02 | BA03 | BA04 | BA05 | BA07 | BA08 | BA09 | BA10 | ||
. Hormones or autacoids | . . Insulins or insulin-like growth factors (IGF) | . . Growth hormones or growth hormone-releasing factors (GRF) | . . Diuresis antihypertensive peptides or atrial natriuretic peptides (ANP) | . . Opiate peptides or analgesic hormones | . Enzymes | . . Oxidoreductases (EC1) | . . . Superoxide dismutases (SOD) | . . Transferases (EC2) | ||||
BA11 | BA12 | BA13 | BA14 | BA15 | BA16 | BA17 | BA19 | |||||
. . Hydrolases (EC3) | . . . acting on glycosyl compounds (EC3.2) | . . . . Alpha-amylases or beta-amylases | . . . acting on peptide bonds (EC3.4) | . . . . Tissue plasminogen activators (t-PA). | . . . . Urokinases | . . . . Chymosins or rennins | . Protease inhibitors | |||||
BA21 | BA22 | BA23 | BA24 | BA25 | BA26 | BA27 | BA28 | BA29 | BA30 | |||
. Cytokines or lymphokines | . . Interferons (IFN) | . . . Alpha-interferons | . . . Beta-interferons | . . . Gamma-interferons | . . Interleukins | . . . Interleukin-2 (IL-2) | . . Tumour necrosis factors (TNF) | . . Lymphotoxins | . . Colony stimulating factors (CSF) | |||
BA31 | BA32 | BA33 | BA34 | BA35 | BA36 | BA38 | BA40 | |||||
. Antigenic peptides for vaccines | . . Viral proteins | . . . Hepatitis viruses | . . . Polioviruses | . . . Human immunodeficiency viruses (HIV) | . . Tumour antigens | . Toxins excluding antigenic proteins | . Serum albumins | |||||
BA41 | BA42 | BA43 | BA44 | BA45 | BA46 | BA47 | BA48 | BA49 | BA50 | |||
. Monoclonal antibodies | . . Immunogens being biological materials | . . . Biological materials derived from animals | . . . . derived from human cells | . . . . . Human tumour cells | . . . . . Human lymph cells | . . . Biological materials derived from plants | . . . Biological materials derived from microorganisms | . . . . derived from fungi or microbial fungi | . . . . derived from bacteria | |||
BA51 | BA53 | BA54 | BA55 | BA56 | BA57 | BA58 | ||||||
. . . . derived from viruses | . . Immunogens being non-biological materials i.e. chemical substances | . . . Tumour antigenic substances | . . . Hormones | . . . Cytokines | . . . . Interferons (IFN) | . . . Antibodies | ||||||
BA61 | BA63 | BA65 | BA67 | |||||||||
. Antibody proteins excluding monoclonal antibodies | . Receptor proteins | . Lipoproteins | . Antibiotics | |||||||||
BA71 | BA72 | BA73 | BA74 | BA75 | BA77 | BA79 | BA80 | |||||
. Amino acids | . . Lysines | . . Threonines | . . Glutamines or glutamic acids | . . Tryptophans | . Fermented foods | . Edible or ornamental plants | . Others | |||||
CA | CA00 KIND OF NUCLEOTIDE FRAGMENT |
CA01 | CA02 | CA03 | CA04 | CA05 | CA06 | CA07 | CA09 | CA10 | ||
. DNA | . . Structural genes | . . . Cutting from chromosomes | . . . cDNA | . . . Synthetic genes | . . . Modification genes | . . . encoding fusion proteins | . . Probes | . . Linkers | ||||
CA11 | CA12 | CA20 | ||||||||||
. RNA | . . mRNA | . Others | ||||||||||
DA | DA00 HOST |
DA01 | DA02 | DA03 | DA05 | DA06 | DA07 | DA08 | DA09 | DA10 | ||
. Plant cells | . Animal cells | . . Human cells | . Bacteria | . . Escherichia coli (E. coli) | . . Bacillus | . . Streptomyces | . . Pseudomonas | . . Coryne types | ||||
DA11 | DA12 | DA20 | ||||||||||
. Fungi | . . Yeasts | . Others | ||||||||||
EA | EA00 KIND OF VECTOR |
EA01 | EA02 | EA03 | EA04 | EA05 | EA06 | EA10 | ||||
. Plant viruses | . Animal viruses | . Bacteriophages | . Plasmids | . . Wild plasmids | . . Cosmid vectors | . Others | ||||||
FA | FA00 IMPROVEMENT OR FUNCTION OF VECTOR |
FA01 | FA02 | FA03 | FA04 | FA05 | FA06 | FA07 | FA08 | FA10 | ||
. Control of transcription or translation | . . Promoters or operators | . . . derived from trp-operons | . . . derived from lac-operons | . . . derived from lambda-phages | . . Enhancers | . . Terminators | . . Ribosome bonding sites | . Markers | ||||
FA11 | FA13 | FA15 | FA17 | FA18 | FA20 | |||||||
. Stabilising injected DNA | . Amplifying copy numbers | . Expansion of host ranges e.g. shuttle vectors | . Secretion of products | . . Signal sequences | . Others | |||||||
GA | GA00 TECHNOLOGY FOR HANDLING CELL OR MICROORGANISM |
GA01 | GA02 | GA03 | GA04 | GA05 | GA06 | GA07 | GA08 | GA09 | GA10 | |
. Cell fusions | . . Origins of parent cells | . . . Animals | . . . . at least one derived from humans | . . . . at least one derived from hybridomas | . . . Plants | . . . Microorganisms | . . Regulation methods for parent cells | . . Fusion means and apparatus used therefor | . . . Electrical fusions | |||
GA11 | GA12 | GA13 | GA14 | GA16 | GA17 | GA18 | GA19 | |||||
. Injection of genes or plasmids | . . Microinjections | . . Ribosome methods | . . Electroporations | . Culture methods or culture apparatus | . . Plant cells or calluses | . . Animal cells | . . Microorganisms | |||||
GA21 | GA23 | GA25 | GA27 | GA30 | ||||||||
. Protoplastisation | . Immortalisation or canceration of cells | . Mutations | . Isolation or screening of cells | . Others | ||||||||
HA | HA00 TECHNOLOGY RELATED TO GENETIC ENGINEERING |
HA01 | HA03 | HA04 | HA06 | HA08 | HA09 | |||||
. Protein engineering | . Isolation or purification of products or proteins | . . using monoclonal antibodies | . Activating or stabilising proteins | . Enzymes related to genetic engineering | . . Restriction enzymes | |||||||
HA11 | HA12 | HA13 | HA14 | HA15 | HA17 | HA19 | HA20 | |||||
. Analysis or diagnosis methods and apparatus therefor | . . using DNA probes | . . . Labels or crosslinking agents | . . . Hybridisation conditions | . . using monoclonal antibodies | . Gene therapy methods | . Methods or apparatus for DNA synthesis and sequencing | . Others |